Records 1 - 5
| Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012 Nov .
Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, Talbot CJ, Wenz F, Wilkinson J, Yarnold J, Dunning AM, Rosenstein BS, West CM, Bentzen SM
| Association of TGFB1 -509 C>T polymorphism with breast cancer: evidence from a meta-analysis involving 23,579 subjects.
Breast cancer research and treatment 2010 Nov 124 (1): 243-9.
Niu Wenquan, Qi Yue, Gao Pingjin, Zhu Dinglia
| Transforming growth factorß1 L10P variant plays an active role on the breast cancer susceptibility in Caucasian: evidence from 10,392 cases and 11,697 controls.
Breast cancer research and treatment 2010 Nov 124 (2): 453-7.
Ma Xiangyu, Chen Chunhai, Xiong Hongyan, Li Yaf
| TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
Breast cancer research and treatment 2010 Oct 123 (3): 857-61.
Gu Dongying, Zhuang Luhong, Huang Huaying, Cao Ping, Wang Danling, Tang Jinhai, Chen Jinf
| TGFB1 L10P polymorphism is associated with breast cancer susceptibility: evidence from a meta-analysis involving 47,817 subjects.
Breast cancer research and treatment 2010 Sep 123 (2): 563-7.
Qiu Li-Xin, Yao Lei, Mao Chen, Chen Bo, Zhan Ping, Xue Kai, Zhang Jian, Yuan Hui, Hu Xi-Ch